Merck KGaA India plant faces partial work stoppage

Merck kgaa
Workers at a German Merck plant in India have gone on strike.

A Merck KGaA plant in Goa, India, has run into labor issues over wages and is now having to take steps to avoid product shortages.

The German drugmaker notified the Bombay Stock Exchange on Wednesday that “a section of the workforce” at the facility had stopped work while in negotiations with management over issues including pay. The company said it is trying to convince the strikers to return to work and resume negotiations.

Because the company has implemented its “business continuity plans,” it said it didn’t expect any impact on the availability of its products or on its finances.

Free Daily Newsletter

Like this story? Subscribe to FiercePharma!

Biopharma is a fast-growing world where big ideas come along daily. Our subscribers rely on FiercePharma as their must-read source for the latest news, analysis and data on drugs and the companies that make them. Sign up today to get pharma news and updates delivered to your inbox and read on the go.

Strikes in India, while not frequent, occasionally arise. GlaxoSmithKline halted production last year at a consumer health plant in India that makes Horlicks nutritional drink products after workers there unexpectedly went on strike.

In 2014, Pfizer acknowledged it temporarily locked employees out of a plant in Thane, India, after workers reportedly tried to stop production and threatened managers.

Suggested Articles

Pfizer says two lots of migraine med Relpax failed to meet microbial standards and may be contaminated with genera pseudomonas and burkholderia.

Emcure has had its share of run-ins with the FDA in the past over the sterility of its plants. Now, it can notch one more black mark on its belt.

The FDA has slapped a warning letter on an Indian solvent recycler that may have contributed to the contamination of blood pressure meds.